
Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients
Keywords: ANOVA; Analysis of Variance; ART; antiretroviral therapy; ARTâ HIV+; ART-naïve HIV-1-infected patients; ART+ HIV+; ART-experienced HIV-1-infected patients; CD40L; CD40-ligand; CMI; cell mediated immunity; DAIDS; Division of Acquired Immunodeficiency Sy